| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3007 | L-770644 | Potent and selective agonist of the human beta3 adrenergic receptor |
|
| DCC3008 | L-778123 Featured | L-778123 is a dual FPTase and GGPTase-I inhibitor, with IC50s of 2 nM and 98 nM respectively. |
|
| DCC3009 | L-841411 | Novel HIV-1 integrase strand transfer inhibitor (INSTI), stabilizing an integrase-single blunt-ended DNA complex |
|
| DCC3010 | L-858051 | Chemically-modified forskolin with greater stability and water solubility than the parent compound |
|
| DCC3011 | L-870812 | Novel inhibitor of HIV-1 and SIV integrase |
|
| DCC3012 | L-94901 | The first organ-selective thyromimetic, lowering plasma low density lipoprotein (LDL) cholesterol and raising plasma high density lipoprotein (HDL) cholesterol levels |
|
| DCC3013 | L-97-1 | Adenosine A1 receptor antagonist, reducing allergic responses to house dust mite in an allergic rabbit model of asthma, improving survival and protecting the kidney in a rat model of cecal ligation and puncture induced sepsis, also improving survival and |
|
| DCC3014 | Lamellarin D | Top1mt inhibitor, targeting mitochondrial DNA |
|
| DCC3015 | la-mem | Glutamate receptor antagonist and radical scavenging agent |
|
| DCC3016 | Lanopepden Mesylate | Novel Peptide Deformylase Inhibitor against Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus |
|
| DCC3017 | laquinimod Sodium | Novel Modulator of autoimmune demyelination |
|
| DCC3018 | Largazole | Potent inhibitor of histone deacetylase |
|
| DCC3019 | Las191859 | Novel, potent and selective CRTh2 antagonist |
|
| DCC3020 | Lasiojasmonate A | Natural fungal phytotoxin, activating the plant jasmonic acid pathway |
|
| DCC3021 | Laspartomycin C | Lipopeptide antibiotic with activity against a range of Gram-positive bacteria including drug-resistant pathogens |
|
| DCC3022 | Lassbio-1135 | Novel dual TRPV1 antagonist and TNF-alpha production inhibitor |
|
| DCC3023 | Lassbio-1359 | Novel adenosine receptor agonist, inducing relaxation of corpus cavernosum; Novel selective phosphodiesterase-4 (PDE4) inhibitor associated with anti-TNF-α properties |
|
| DCC3024 | Lassbio-1366 | Novel Adenosine A2a Receptor Agonist, Attenuating the Progression of Monocrotaline-induced Pulmonary Hypertension |
|
| DCC3025 | Lassbio-1524 | Novel IKK-β inhibitor, reducing the secretion of TNF-α, IL-1β, IL-6, IL-12, IFN-γ and increased secretion of IL-10, protecting gastrointestinal homeostasis |
|
| DCC3026 | Lassbio-1829 Hydrochloride | Novel orally active IKK2 inhibitor |
|
| DCC3027 | Lassbio-1911 | Novel Potent and Selective Histone Deacetylase 6 (HDAC6) Inhibitor |
|
| DCC3028 | Latonduine A | Natural F508del-CFTR corrector, inhibiting both PARP-3 and -16, regulating the activity of the unfolded protein response activator inositol-requiring enzyme (IRE-1) via modulation of the level of its ribosylation by PARP-16 |
|
| DCC3029 | Latonduine B | Natural F508del-CFTR trafficking corrector, targeting poly(ADP-ribose) polymerase (PARP) |
|
| DCC3030 | Latrunculin A | Disruptor of microfilament-mediated processes |
|
| DCC3031 | Laulimalide | Microtubule stabilzer, potently inhibiting cellular proliferation in cancer cell lines |
|
| DCC3032 | Laxaphycin A | Natural antifungal and cytotoxic agent |
|
| DCC3033 | Laxaphycin B | Natural inhibitor of the proliferation of sensitive and resistant human cancer cell lines and this inhibitory activity is strongly increased in the presence of laxaphycin A |
|
| DCC3034 | Lb30870 | Potent, orally active, selective and direct thrombin inhibitor |
|
| DCC3035 | Lb30889 | Prodrug of LB30870 as potent, orally active, selective and direct thrombin inhibitor |
|
| DCC3036 | L-bmaa Hydrochloride | Neurotoxic amino acid |
|
